BI
BMY icon

Berkeley Inc’s Bristol-Myers Squibb BMY Stock Holding History

Berkeley Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-36,897
Closed -$2.14M – 71
2023
Q3 		$2.14M Sell
36,897
-8,110
-18% -$497K 1.46% 21
2023
Q2 		$2.88M Buy
45,007
+4,084
+10% +$274K 1.94% 19
2023
Q1 		$2.84M Buy
40,923
+1,812
+5% +$128K 2.06% 17
2022
Q4 		$2.81M Sell
39,111
-29
-0.1% -$2.19K 2.12% 16
2022
Q3 		$2.78M Buy
39,140
+1,308
+3% +$94.9K 2.34% 13
2022
Q2 		$2.91M Buy
37,832
+1,083
+3% +$82.5K 2.33% 12
2022
Q1 		$2.68M Buy
36,749
+9,815
+36% +$659K 1.87% 14
2021
Q4 		$1.68M Buy
26,934
+10,278
+62% +$603K 1.12% 30
2021
Q3 		$986K Buy
16,656
+1,114
+7% +$73.4K 0.73% 39
2021
Q2 		$1.04M Buy
15,542
+4,019
+35% +$262K 0.74% 38
2021
Q1 		$727K Buy
+11,523
New +$717K 0.54% 47

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Berkeley Inc's BMY Position: Q4 2023 in Review

Berkeley Inc sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 36,897 shares — an estimated $2.14M sold.

Berkeley Inc first reported a position in BMY in Q1 2021 and held it in 11 quarters. The position peaked at $2.91M in Q2 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • Berkeley Inc reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
  • Berkeley Inc sold 36,897 Bristol-Myers Squibb shares in Q4 2023, an estimated $2.14M.
  • Berkeley Inc first reported a position in Bristol-Myers Squibb in Q1 2021 and held it in 11 quarters.
  • Berkeley Inc's Bristol-Myers Squibb position peaked at $2.91M in Q2 2022.
  • 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Berkeley Inc's 13F filing for Q4 2023, filed 4 Mar 2025.